COVID-19 Incidence, Risk Factors, Impact, and Related Stigma Among a Cohort of Persons With HIV in Washington, DC.
Journal
Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005
Informations de publication
Date de publication:
15 Aug 2024
15 Aug 2024
Historique:
received:
05
12
2023
accepted:
09
04
2024
medline:
10
7
2024
pubmed:
10
7
2024
entrez:
10
7
2024
Statut:
ppublish
Résumé
Studies on the incidence of COVID-19 among persons with HIV (PWHs) present varied results. Few studies have investigated the impact of COVID-19 infection on health and socioeconomic factors or COVID-19 stigma. We sought to measure the incidence and severity of COVID-19 infection among a cohort of PWHs, characterize associated risk factors and impact, and document perceptions of COVID-19-related stigma. Data for this cross-sectional study come from the COVID-19 survey of participants in the DC Cohort longitudinal study from October 30, 2020, through December 31, 2022. Survey results were linked to electronic health records, including HIV laboratory test results and COVID test results. We conducted analyses comparing demographic, socioeconomic, HIV measures, and stigma among those with and without self-reported COVID-19. Of 1972 survey respondents, 17% self-reported COVID-19 infection, with the greatest incidence in the Omicron wave of the pandemic. We found statistically significant differences by age, employment status, essential worker status, education, and household income. Longer duration of HIV diagnosis was associated with greater incidence of COVID-19. PWHs who were overweight or obese had a greater incidence of COVID-19 compared with those who were not. Over 40% of PWHs with COVID-19 reported experiencing at least 1 form of COVID-19-related stigma. We observed a high incidence of COVID-19 infection among PWHs in DC. Furthermore, a substantial proportion of PWHs with COVID-19 reported experiencing COVID-19-related stigma. These findings add to the existing literature on COVID-19 coinfection among PWHs and highlight the need for awareness and support for those experiencing COVID-19 stigma.
Sections du résumé
BACKGROUND
BACKGROUND
Studies on the incidence of COVID-19 among persons with HIV (PWHs) present varied results. Few studies have investigated the impact of COVID-19 infection on health and socioeconomic factors or COVID-19 stigma. We sought to measure the incidence and severity of COVID-19 infection among a cohort of PWHs, characterize associated risk factors and impact, and document perceptions of COVID-19-related stigma.
METHODS
METHODS
Data for this cross-sectional study come from the COVID-19 survey of participants in the DC Cohort longitudinal study from October 30, 2020, through December 31, 2022. Survey results were linked to electronic health records, including HIV laboratory test results and COVID test results. We conducted analyses comparing demographic, socioeconomic, HIV measures, and stigma among those with and without self-reported COVID-19.
RESULTS
RESULTS
Of 1972 survey respondents, 17% self-reported COVID-19 infection, with the greatest incidence in the Omicron wave of the pandemic. We found statistically significant differences by age, employment status, essential worker status, education, and household income. Longer duration of HIV diagnosis was associated with greater incidence of COVID-19. PWHs who were overweight or obese had a greater incidence of COVID-19 compared with those who were not. Over 40% of PWHs with COVID-19 reported experiencing at least 1 form of COVID-19-related stigma.
CONCLUSION
CONCLUSIONS
We observed a high incidence of COVID-19 infection among PWHs in DC. Furthermore, a substantial proportion of PWHs with COVID-19 reported experiencing COVID-19-related stigma. These findings add to the existing literature on COVID-19 coinfection among PWHs and highlight the need for awareness and support for those experiencing COVID-19 stigma.
Identifiants
pubmed: 38985440
doi: 10.1097/QAI.0000000000003447
pii: 00126334-202408150-00003
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
429-438Subventions
Organisme : National Institute of Allergy and Infectious Diseases
ID : 1R24AI152598-01
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no funding or conflicts of interest to disclose.
Références
University JH. The Coronavirus Resource Center; COVID-19 Dashboard. Available at: https://www.coronavirus.jhu.edu/map.html
Prevention CfDCa COVID Data Tracker. [cited October 2, 2023].
Harden JD Coronavirus Infection Rate in DC Region Is 3 Times Higher than outside Metro Area, in Washington Post; 2020. Washington, DC.
Adab P, Haroon S, O'Hara ME, et al. Comorbidities and covid-19. BMJ. 2022;377:o1431.
Mackey K, Ayers CK, Kondo KK, et al. Racial and ethnic disparities in COVID-19-related infections, hospitalizations, and deaths: a systematic review. Ann Intern Med. 2021;174:362–373.
Khanijahani A, Iezadi S, Gholipour K, et al. A systematic review of racial/ethnic and socioeconomic disparities in COVID-19. Int J Equity Health. 2021;20:248.
Levy ME, Greenberg AE, Hart R, et al. High burden of metabolic comorbidities in a citywide cohort of HIV outpatients: evolving health care needs of people aging with HIV in Washington, DC. HIV Med. 2017;18:724–735.
Marcus JL, Leyden WA, Alexeeff SE, et al. Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000-2016. JAMA Netw Open. 2020;3:e207954.
Gervasoni C, Meraviglia P, Riva A, et al. Clinical features and outcomes of patients with human immunodeficiency virus with COVID-19. Clin Infect Dis. 2020;71:2276–2278.
Sigel K, Swartz T, Golden E, et al. Coronavirus 2019 and people living with human immunodeficiency virus: outcomes for hospitalized patients in New York city. Clin Infect Dis. 2020;71:2933–2938.
Cooper TJ, Woodward BL, Alom S, et al. Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review. HIV Med. 2020;21:567–577.
Dandachi D, Geiger G, Montgomery MW, et al. Characteristics, comorbidities, and outcomes in a multicenter registry of patients with human immunodeficiency virus and coronavirus disease 2019. Clin Infect Dis. 2021;73:e1964–e1972.
Spinelli MA, Jones BLH, Gandhi M. COVID-19 outcomes and risk factors among people living with HIV. Curr HIV/AIDS Rep. 2022;19:425–432.
Weiser JK, Tie Y, Beer L, et al. Racial/ethnic and income disparities in the prevalence of comorbidities that are associated with risk for severe COVID-19 among adults receiving HIV care, United States, 2014-2019. J Acquir Immune Defic Syndr. 2021;86:297–304.
Del Amo J, Polo R, Moreno S, et al. Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy. Ann Intern Med. 2021;174:581–582.
Huang J, Xie N, Hu X, et al. Epidemiological, virological and serological features of coronavirus disease 2019 (COVID-19) cases in people living with human immunodeficiency virus in Wuhan: a population-based cohort study. Clin Infect Dis. 2021;73:e2086–e2094.
Tesoriero JM, Swain CAE, Pierce JL, et al. COVID-19 outcomes among persons living with or without diagnosed HIV infection in New York state. JAMA Netw Open. 2021;4:e2037069.
Sachdev D, Mara E, Hsu L, et al. COVID-19 susceptibility and outcomes among people living with HIV in San Francisco. J Acquir Immune Defic Syndr. 2021;86:19–21.
Gronholm PC, Nosé M, van Brakel WH, et al. Reducing stigma and discrimination associated with COVID-19: early stage pandemic rapid review and practical recommendations. Epidemiol Psychiatr Sci. 2021;30:e15.
Ransing R, Ramalho R, de Filippis R, et al. Infectious disease outbreak related stigma and discrimination during the COVID-19 pandemic: drivers, facilitators, manifestations, and outcomes across the world. Brain Behav Immun. 2020;89:555–558.
Kalichman SC, Katner H, Banas E, et al. Cumulative effects of stigma experiences on retention in HIV care among men and women in the rural Southeastern United States. AIDS Patient Care STDS. 2020;34:484–490.
House TW. National HIV/AIDS Strategy for the United States 2022–2025; 2021. Washington, DC.
Logie C, Gadalla TM. Meta-analysis of health and demographic correlates of stigma towards people living with HIV. AIDS Care. 2009;21:742–753.
Anderson J, Fenton K. HIV related stigma: a dangerous roadblock. BMJ. 2022;379:o2989.
Jarolimova J, Yan J, Govere S, et al. Medical mistrust and stigma associated with COVID-19 among people living with HIV in South Africa. AIDS Behav. 2021;25:3967–3977.
Hall A, Joseph O, Devlin S, et al. “That same stigma…that same hatred and negativity:” a qualitative study to understand stigma and medical mistrust experienced by people living with HIV diagnosed with COVID-19. BMC Infect Dis. 2021;21:1066.
Krier S, Bozich C, Pompa R, et al. Assessing HIV-related stigma in healthcare settings in the era of the COVID-19 pandemic, Pittsburgh, Pennsylvania. AIDS Behav. 2020;24:2483–2485.
Greenberg AE, Hays H, Castel AD, et al. Development of a large urban longitudinal HIV clinical cohort using a web-based platform to merge electronically and manually abstracted data from disparate medical record systems: technical challenges and innovative solutions. J Am Med Inform Assoc. 2016;23:635–643.
Castel AD, Barth S, Wilbourn BC, et al. Trends in COVID-19 vaccine hesitancy and uptake among persons living with HIV in Washington, DC. J Acquir Immune Defic Syndr. 2023;94:124–134.
Harris PA, Taylor R, Thielke R, et al. Research Electronic Data Capture (REDCap)—a Metadata-Driven Methodology and Workflow Process for Providing Translational Research Informatics Support. (1532-0480).
Harris PA, Taylor R, Minor BL, et al. The REDCap Consortium: Building an International Community of Software Platform Partners. (1532-0480).
Kaiser Permanente. KP Research Bank COVID-19 Surveys; 2020. Available at: https://researchbank.kaiserpermanente.org/wp-content/uploads/2021/05/KPRB-COVID-19-Survey_-summary.pdf
Wilbourn B, Saafir-Callaway B, Jair K, et al. Characterization of HIV risk behaviors and clusters using HIV-transmission cluster engine among a cohort of persons living with HIV in Washington, DC. AIDS Res Hum Retroviruses. 2021;37:706–715.
Stanford. COVID19 Interview Items for Vulnerable Populations; 2023. Available at: https://clelandcm.github.io/COVID19-Interview-Items/COVID-Items.html#stanford
Behar-Zusman V, Chavez JV, Gattamorta K. Developing a measure of the impact of COVID-19 social distancing on household conflict and cohesion. Fam Process. 2020;59:1045–1059.
ATN. COVID Questionnaire Draft; 2020. Available at: https://clelandcm.github.io/COVID19-Interview-Items/COVID-Items.html#atn
CDC. Human Infection with 2019 Novel Coronavirus Case Report Form Interviewer Information Case Classification and Identification; 2023. Available at: https://www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdf
City University of New York Institute for Implementation Science in Population Health. Baseline Questionnaire for the Communities, Households and SARS/COV-2 Epidemiology (CHASE) COVID Study; 2020. Available at: https://cunyisph.org/wp-content/uploads/CHASE-COVID_baseline_V2.1.pdf
Kalichman S. Kalichman Covid-19 Assessment; 2020. Available at: https://clelandcm.github.io/COVID19-Interview-Items/COVID-Items.html#kalichman-covid-19-assessment
Agyeman AA, Chin KL, Landersdorfer CB, et al. Smell and taste dysfunction in patients with COVID-19: a systematic review and meta-analysis. Mayo Clin Proc. 2020;95:1621–1631.
Su Y, Yuan D, Chen DG, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881–895.e20.
Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277:2251–2261.
Christopoulos KA, Neilands TB, Hartogensis W, et al. Internalized HIV stigma is associated with concurrent viremia and poor retention in a cohort of US patients in HIV care. J Acquir Immune Defic Syndr. 2019;82:116–123.
Earnshaw VA, Smith LR, Chaudoir SR, et al. HIV stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework. AIDS Behav. 2013;17:1785–1795.
Tang ME, Gaufin T, Anson R, et al. People with HIV have a higher risk of COVID-19 diagnosis but similar outcomes to the general population. HIV Med. 2022;23:1069–1077.
Spinelli MA, Lynch KL, Yun C, et al. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study. Lancet HIV. 2021;8:e334–e341.
Chang JJ, Bruxvoort K, Chen LH, et al. Brief report: COVID-19 testing, characteristics, and outcomes among people living with HIV in an integrated health system. J Acquir Immune Defic Syndr. 2021;88:1–5.
Braunstein SL, Lazar R, Wahnich A, et al. Coronavirus disease 2019 (COVID-19) infection among people with human immunodeficiency virus in New York city: a population-level analysis of linked surveillance data. Clin Infect Dis. 2021;72:e1021–e1029.
Lindberg MH, Chen G, Olsen JA, et al. Combining education and income into a socioeconomic position score for use in studies of health inequalities. BMC Public Health. 2022;22:969.
de Leeuw AJM, Oude Luttikhuis MAM, Wellen AC, et al. Obesity and its impact on COVID-19. J Mol Med (Berl). 2021;99:899–915.
Yuan GF, Qiao S, Li X Bridging internalized HIV stigma and depressive symptoms among people living with HIV in China during the COVID-19 pandemic: a network analysis. Front Public Health. 2023;11:1306414.
Gruszczyńska E, Rzeszutek M. Daily stigma and daily emotional well-being among people living with HIV: testing a buffering hypothesis of social support during the COVID-19 pandemic. Appl Psychol Health Well Being. 2024;16:477–496.
Rueda S, Mitra S, Chen S, et al. Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses. BMJ Open. 2016;6:e011453.
Feyissa GT, Lockwood C, Woldie M, et al. Reducing HIV-related stigma and discrimination in healthcare settings: a systematic review of quantitative evidence. PLoS One. 2019;14:e0211298.
Ma PHX, Chan ZCY, Loke AY Self-stigma reduction interventions for people living with HIV/AIDS and their families: a systematic review. AIDS Behav. 2019;23:707–741.
Pantelic M, Steinert JI, Park J, et al. ‘Management of a spoiled identity’: systematic review of interventions to address self-stigma among people living with and affected by HIV. BMJ Glob Health. 2019;4:e001285.
HHS. Ending the HIV Epidemic Priority Jurisdictions; 2023.